Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1064 | 1064 | 1094 | 1141 | 1431 | 2258 |
Fund Return | 6.35% | 6.35% | 9.45% | 4.48% | 7.44% | 8.49% |
Place in category | 406 | 406 | 456 | 319 | 160 | 14 |
% in Category | 67 | 67 | 79 | 64 | 34 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth | 4.09B | 9.28 | 8.01 | 10.29 | ||
Renaissance Global Growth Class F | 4.09B | 9.63 | 9.41 | 11.75 | ||
Renaissance International Equity | 1.75B | 6.02 | 3.14 | 7.03 | ||
Renaissance US Equity Income F Pr | 1.39B | 7.74 | 8.36 | 10.60 | ||
Renaissance US Equity Income Fund | 1.39B | 7.41 | 7.00 | 9.12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC International Equity Sr F | 2.28B | 8.66 | 5.65 | 7.54 | ||
RBC International Equity Fund D USD | 2.28B | 8.59 | 5.36 | 7.26 | ||
Renaissance International Equity | 1.75B | 6.02 | 3.14 | 7.03 | ||
Manulife World Inv Cl Sr Adv | 1.65B | 7.78 | 1.82 | 5.96 | ||
Manulife World Inv Cl Sr F | 1.65B | 8.14 | 3.21 | 7.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.91 | 873.1 | -2.74% | |
ASML Holding | NL0010273215 | 3.13 | 811.40 | -2.56% | |
Shin-Etsu Chemical | JP3371200001 | 2.95 | 5,989.0 | -1.40% | |
Keyence | JP3236200006 | 2.94 | 69,360.0 | +0.20% | |
Taiwan Semiconductor | US8740391003 | 2.91 | 136.23 | +0.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Strong Sell | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review